X @Bloomberg
INNOVENT BIOINNOVENT BIO(HK:01801) Bloomberg·2025-06-27 08:14

Regulatory Approval - China approves Innovent Biologics' weight loss drug [1] Competitive Landscape - Innovent Biologics becomes a potent homegrown competitor in the weight loss drug market [1] - The approval intensifies competition against foreign giants Novo Nordisk and Eli Lilly [1]